Results of the present study have demonstrated that a dose-dependent increase of EPO concentration in CSF as systemic administration of different doses of EPO for rat via i.p. injection, and systemic administration of high-dose EPO exerted neuroprotective effects on a PD model of rats behaviorally and immunohistochemically. The gene discussed is EPO; the disease is Parkinson disease.